BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22039883)

  • 41. Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases.
    Matsuda H; Fukuda N; Ueno T; Tahira Y; Ayame H; Zhang W; Bando T; Sugiyama H; Saito S; Matsumoto K; Mugishima H; Serie K
    J Am Soc Nephrol; 2006 Feb; 17(2):422-32. PubMed ID: 16371433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of the N-terminal acylamido group of imidazole- and pyrrole-containing polyamides on DNA sequence specificity and binding affinity.
    Westrate L; Mackay H; Brown T; Nguyen B; Kluza J; Wilson WD; Lee M; Hartley JA
    Biochemistry; 2009 Jun; 48(24):5679-88. PubMed ID: 19419200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of major-groove-binding proteins by pyrrole-imidazole polyamides with an Arg-Pro-Arg positive patch.
    Bremer RE; Baird EE; Dervan PB
    Chem Biol; 1998 Mar; 5(3):119-33. PubMed ID: 9545429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes.
    Konrad TA; Karger A; Hackl H; Schwarzinger I; Herbacek I; Wieser R
    J Leukoc Biol; 2009 Oct; 86(4):813-22. PubMed ID: 19605700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia.
    Tanaka A; Nakano TA; Nomura M; Yamazaki H; Bewersdorf JP; Mulet-Lazaro R; Hogg S; Liu B; Penson A; Yokoyama A; Zang W; Havermans M; Koizumi M; Hayashi Y; Cho H; Kanai A; Lee SC; Xiao M; Koike Y; Zhang Y; Fukumoto M; Aoyama Y; Konuma T; Kunimoto H; Inaba T; Nakajima H; Honda H; Kawamoto H; Delwel R; Abdel-Wahab O; Inoue D
    Blood; 2022 Aug; 140(8):875-888. PubMed ID: 35709354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells.
    Rommer A; Steinmetz B; Herbst F; Hackl H; Heffeter P; Heilos D; Filipits M; Steinleitner K; Hemmati S; Herbacek I; Schwarzinger I; Hartl K; Rondou P; Glimm H; Karakaya K; Krämer A; Berger W; Wieser R
    PLoS One; 2013; 8(2):e56308. PubMed ID: 23457546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia.
    Vázquez I; Maicas M; Cervera J; Agirre X; Marin-Béjar O; Marcotegui N; Vicente C; Lahortiga I; Gomez-Benito M; Carranza C; Valencia A; Brunet S; Lumbreras E; Prosper F; Gómez-Casares MT; Hernández-Rivas JM; Calasanz MJ; Sanz MA; Sierra J; Odero MD
    Haematologica; 2011 Oct; 96(10):1448-56. PubMed ID: 21750091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of the RUNX1-EVI1 fusion gene in leukemogenesis.
    Maki K; Yamagata T; Mitani K
    Cancer Sci; 2008 Oct; 99(10):1878-83. PubMed ID: 19016745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EVI1 promotes tumor growth via transcriptional repression of MS4A3.
    Heller G; Rommer A; Steinleitner K; Etzler J; Hackl H; Heffeter P; Tomasich E; Filipits M; Steinmetz B; Topakian T; Klingenbrunner S; Ziegler B; Spittler A; Zöchbauer-Müller S; Berger W; Wieser R
    J Hematol Oncol; 2015 Mar; 8():28. PubMed ID: 25886616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mice carrying a hypomorphic Evi1 allele are embryonic viable but exhibit severe congenital heart defects.
    Bard-Chapeau EA; Szumska D; Jacob B; Chua BQ; Chatterjee GC; Zhang Y; Ward JM; Urun F; Kinameri E; Vincent SD; Ahmed S; Bhattacharya S; Osato M; Perkins AS; Moore AW; Jenkins NA; Copeland NG
    PLoS One; 2014; 9(2):e89397. PubMed ID: 24586749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sequence-specific DNA alkylation and transcriptional inhibition by long-chain hairpin pyrrole-imidazole polyamide-chlorambucil conjugates targeting CAG/CTG trinucleotide repeats.
    Asamitsu S; Kawamoto Y; Hashiya F; Hashiya K; Yamamoto M; Kizaki S; Bando T; Sugiyama H
    Bioorg Med Chem; 2014 Sep; 22(17):4646-57. PubMed ID: 25127467
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of a novel E-box binding pyrrole-imidazole polyamide inhibiting MYC-driven cell proliferation.
    Mishra R; Watanabe T; Kimura MT; Koshikawa N; Ikeda M; Uekusa S; Kawashima H; Wang X; Igarashi J; Choudhury D; Grandori C; Kemp CJ; Ohira M; Verma NK; Kobayashi Y; Takeuchi J; Koshinaga T; Nemoto N; Fukuda N; Soma M; Kusafuka T; Fujiwara K; Nagase H
    Cancer Sci; 2015 Apr; 106(4):421-9. PubMed ID: 25611295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting the ICB2 site of the topoisomerase IIalpha promoter with a formamido-pyrrole-imidazole-pyrrole H-pin polyamide.
    Franks A; Tronrud C; Kiakos K; Kluza J; Munde M; Brown T; Mackay H; Wilson WD; Hochhauser D; Hartley JA; Lee M
    Bioorg Med Chem; 2010 Aug; 18(15):5553-61. PubMed ID: 20615712
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phosphorylation of the leukemic oncoprotein EVI1 on serine 196 modulates DNA binding, transcriptional repression and transforming ability.
    White DJ; Unwin RD; Bindels E; Pierce A; Teng HY; Muter J; Greystoke B; Somerville TD; Griffiths J; Lovell S; Somervaille TC; Delwel R; Whetton AD; Meyer S
    PLoS One; 2013; 8(6):e66510. PubMed ID: 23776681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of EVI1 in normal and leukemic cells.
    Buonamici S; Chakraborty S; Senyuk V; Nucifora G
    Blood Cells Mol Dis; 2003; 31(2):206-12. PubMed ID: 12972028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of gene expression by small molecules.
    Gottesfeld JM; Neely L; Trauger JW; Baird EE; Dervan PB
    Nature; 1997 May; 387(6629):202-5. PubMed ID: 9144294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1.
    Lugthart S; Figueroa ME; Bindels E; Skrabanek L; Valk PJ; Li Y; Meyer S; Erpelinck-Verschueren C; Greally J; Löwenberg B; Melnick A; Delwel R
    Blood; 2011 Jan; 117(1):234-41. PubMed ID: 20855866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EVI1 Interferes with Myeloid Maturation via Transcriptional Repression of Cebpa, via Binding to Two Far Downstream Regulatory Elements.
    Wilson M; Tsakraklides V; Tran M; Xiao YY; Zhang Y; Perkins AS
    J Biol Chem; 2016 Jun; 291(26):13591-607. PubMed ID: 27129260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel pyrrole-imidazole polyamide targets Aurora kinase A and suppresses tumor growth in vivo.
    Li M; Lu D; Cheng Y; Wu C; Zhang J; Shi W; Ding Z; Li Y; Cheng B; Lin X; Shao X; Li H; Fang L; Liu K; Su W
    Biochem Biophys Res Commun; 2021 Sep; 571():167-173. PubMed ID: 34330060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR.
    Boyd KE; Xiao YY; Fan K; Poholek A; Copeland NG; Jenkins NA; Perkins AS
    Blood; 2006 Jan; 107(2):733-41. PubMed ID: 16204320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.